Evotec SE (EVO) Profit After Tax (2009 - 2025)
Evotec SE (EVO) reported Profit After Tax of -$120.4 million for Q4 2025, up 42.51% on a YoY basis from -$84.5 million in Q4 2024, and down 238848.18% sequentially from -$50371.1 in Q3 2025.
Evotec SE (EVO) Profit After Tax (2009 - 2025) Analysis & Trends
Evotec SE (EVO) has 9 years of Profit After Tax data on file, last reported at -$120.4 million in Q4 2025.
- For the quarter ending Q4 2025, Profit After Tax rose 42.51% year-over-year to -$120.4 million; the trailing twelve-month figure through Dec 2025 stood at -$329.8 million (down 10.09% YoY), and the FY2025 full-year result was -$120.5 million, up 42.49% from the prior year.
- Profit After Tax fell to -$120.4 million in Q4 2025, from -$50371.1 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $246.3 million in Q4 2021 to a low of -$209.4 million in Q4 2024.
- A 5-year average of -$23.5 million and a median of -$29810.4 in 2022 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax surged 9714.16% in 2021 and slumped 229.31% in 2022, its largest moves.
- Tracing EVO's Profit After Tax over 5 years: stood at $246.3 million in 2021, then tumbled by 172.84% to -$179.4 million in 2022, then surged by 49.7% to -$90.2 million in 2023, then sank by 132.08% to -$209.4 million in 2024, then surged by 42.51% to -$120.4 million in 2025.
- Business Quant data shows EVO's Profit After Tax at -$120.4 million in Q4 2025, -$50371.1 in Q3 2025, and -$209.4 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -120.36 Mn |
| Sep 30, 2025 | -50,371.08 |
| Dec 31, 2024 | -209.36 Mn |
| Sep 30, 2024 | -43,526.83 |
| Dec 31, 2023 | -90.21 Mn |
| Sep 30, 2023 | 42,406.04 |
| Jun 30, 2023 | -16,256.55 |
| Dec 31, 2022 | -179.36 Mn |
| Sep 30, 2022 | 47,666.17 |
| Jun 30, 2022 | -29,810.36 |
| Mar 31, 2022 | -82,202.26 |
| Dec 31, 2021 | 246.25 Mn |
| Sep 30, 2021 | 158,344.09 |
| Jun 30, 2021 | 72,274.35 |
| Mar 31, 2021 | 63,571.06 |
| Dec 31, 2020 | 7.48 Mn |
| Sep 30, 2020 | -1,646.99 |
| Dec 31, 2019 | 41.30 Mn |
| Sep 30, 2010 | 835.45 |
| Jun 30, 2010 | 1,710.83 |